Skip to main content
. 2018 Sep 1;11(9):4305–4318.

Table 1.

Detailed information of the 20 glioma patients

Patient number Sex Age Pathologic diagnosis Tumor grade (WHO) HIF-1α mRNA level* BAG3 mRNA level*
1 Female 40 Astrocytoma I 5.452 5.173
2 Male 19 Astrocytoma I 2.701 4.441
3 Male 43 Astrocytoma II 0.875 0.211
4 Female 24 Astrocytoma II 5.103 3.629
5 Female 58 Astrocytoma II 0.913 0.347
6 Female 58 Astrocytoma II 5.184 4.405
7 Male 53 Astrocytoma II 2.377 1.383
8 Male 58 Astrocytoma II 7.120 5.041
9 Male 61 Astrocytoma II 0.346 0.352
10 Male 73 Astrocytoma II 2.511 3.704
11 Male 52 Glioblastoma IV 1.000 1.000
12 Male 39 Glioblastoma IV 1.646 3.106
13 Male 20 Glioblastoma IV 1.384 1.901
14 Female 39 Glioblastoma IV 0.485 1.049
15 Male 59 Glioblastoma IV 2.379 3.619
16 Female 44 Glioblastoma IV 1.957 2.210
17 Female 75 Glioblastoma IV 1.161 0.262
18 Male 30 Glioblastoma IV 10.966 7.867
19 Female 50 Glioblastoma IV 1.292 0.661
20 Female 73 Glioblastoma IV 3.760 2.682
*

HIF-1α and BAG3 mRNA expression levels were relative to β-actin.